Scientific Director, Scientific Affairs
Labcorp, Switzerland
Robert Nelson PhD is a member of the Labcorp Drug Development (formally Covance) Scientific Affairs Early Scientific Engagement team, partnering with clients and internal staff to find innovative solutions to bioanalytical science, technology and regulatory challenges. A primary area of focus for Rob is bioanalytical strategy supporting clinical and nonclinical studies, including pharmacokinetic, pharmacodynamics, biomarker and immunogenicity endpoints. Rob received his BSc in Pharmacology and his PhD in Molecular Physiology from the University of Edinburgh before undertaking research then biotechnology industry roles.